GC Genome Corporation, a leading diagnostics company, announced that it will present data showcasing deep learning algorithm utilizing methylation markers that can identify lung cancer at the European Society for Medical Oncology 2023 Congress, taking place from October 20-24 in Madrid, Spain.
